| Maher Shenouda, PHARMD | |
|
436 5th Ave, Kotzebue, AK 99752-9975 | |
| (907) 442-7457 | |
| (907) 442-7245 |
| Full Name | Maher Shenouda |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 436 5th Ave, Kotzebue, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417474644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | S017037 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maher Shenouda, PHARMD 7177 W Fleetwood Ln, Glendale, AZ 85303-7607 Ph: () - | Maher Shenouda, PHARMD 436 5th Ave, Kotzebue, AK 99752-9975 Ph: (907) 442-7457 |
News Archive
Over 300,000 immigrants a year are detained by United States Immigration and Customs Enforcement (USICE), a branch of the Department of Homeland Security. These immigrants are held at facilities run by, or under contract with, USICE. In recent years, studies by community-based organizations, the government, and the media have identified systemic deficiencies in the provision of healthcare to immigrant detainees and have described incidents of inadequate medical treatment, suffering and, in some cases, death.
For patients with dementia who have symptoms of aggression and agitation, interventions such as outdoor activities, massage and touch therapy may be more effective treatments than medication in some cases, suggests a study publishing Oct. 14 in Annals of Internal Medicine.
Since 2003, breast augmentation utilizing stem cells from autologous fat has been developed enabling silicon-free breast reconstruction following cancer surgery. Till now though, it was unclear whether this might reactivate the cancer again. However, University of Pittsburgh researchers led by Prof. Albert Donnenberg have now demonstrated that stem cell-enriched autologous fat is safe even in the presence of inactive tumor cells.
The drug rimonabant was developed as a treatment for obesity and its myriad of serious health consequences. Despite having its desired effects on weight, which it decreased, and on levels of glucose and fats in the blood, rimonabant was never approved for use in the US because of serious neurological side effects including depression and anxiety. Now, a team of researchers, led by George Kunos, at the National Institutes of Health, Bethesda, and Alexandros Makriyannis, at Northeastern University, Boston, have developed a drug that has the same positive effects in mice on levels of glucose and fats in the blood as rimonabant but none of the neurological side effects.
› Verified 3 days ago
Jason Marc Maille, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Avenue, Kotzebue, AK 99752 Phone: 907-442-7182 | |
Dr. Joshua Fillible, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Ave, Kotzebue, AK 99752 Phone: 907-442-7462 | |
Mr. Freddy Rukema Kaniki, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 439 5th & Grizzly, Kotzebue, AK 99752 Phone: 907-442-7182 | |
Denzel Mann, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Avenue, Maniilaq Health Center, Kotzebue, AK 99752 Phone: 757-254-4481 | |
Paul F Nunamaker, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 439 5th & Grizzly, Maniilaq Association, Kotzebue, AK 99752 Phone: 907-442-7182 | |
Meredith A Dean, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 436 5th Ted Stevens Way, Kotzebue, AK 99752 Phone: 907-442-7182 Fax: 907-442-7309 |